UPDATE: AngioDynamics (ANGO) Tops Q3 EPS by 1c; Cuts FY EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $12.25 +4.43%
Financial Fact:
Amortization of intangibles: 4.24M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Amortization of intangibles: 4.24M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
(Updated - April 7, 2016 4:04 PM EDT)
AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.15, $0.01 better than the analyst estimate of $0.14. Revenue for the quarter came in at $87.4 million versus the consensus estimate of $85.07 million.
The company sees FY15 EPS of $0.54 - $0.58, from $0.59 - $0.63 prior and the consensus of $0.60.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- Real Industry (RELY) Tops Q3 EPS by 15c; offers guidance
- BillionToOne, Inc. (BLLN) Tops Q3 EPS by 23c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
